BRUKER CORPORATION Operating Expenses
BRUKER CORPORATION (BRKR) reported Operating Expenses of $481.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- BRUKER CORPORATION operating expenses for the quarter ending 2026-06-30 was $481.30M, a 39.10% increase year-over-year.
- BRUKER CORPORATION operating expenses for the quarter ending 2026-03-31 was $369.60M, a 2.84% increase year-over-year.
- BRUKER CORPORATION operating expenses for the quarter ending 2025-12-31 was $372.90M, a 11.47% decline year-over-year.
- BRUKER CORPORATION operating expenses for the quarter ending 2025-09-30 was $431.20M, a 22.95% increase year-over-year.
- BRUKER CORPORATION operating expenses for fiscal 2025 was $1.51B, a 8.10% increase from fiscal 2024.
- BRUKER CORPORATION operating expenses for fiscal 2024 was $1.40B, a 29.73% increase from fiscal 2023.
- BRUKER CORPORATION operating expenses for fiscal 2023 was $1.08B, a 23.30% increase from fiscal 2022.
- BRUKER CORPORATION operating expenses for fiscal 2022 was $873.00M, a 9.63% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $481.30M 10-Q · filed 2026-08-05 | $850.90M 10-Q · filed 2026-08-05 | $1.22B derived: sum of 3 quarters · filed 2026-08-05 | $1.66B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $369.60M 10-Q · filed 2026-05-07 | $742.50M derived: sum of 2 quarters · filed 2026-05-07 | $1.17B derived: sum of 3 quarters · filed 2026-05-07 | $1.52B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $372.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $804.10M derived: sum of 2 quarters · filed 2026-02-27 | $1.15B derived: sum of 3 quarters · filed 2026-08-05 | $1.51B 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $431.20M 10-Q · filed 2025-11-05 | $777.20M derived: sum of 2 quarters · filed 2026-08-05 | $1.14B 10-Q · filed 2025-11-05 | $1.56B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $346.00M 10-Q · filed 2026-08-05 | $705.40M 10-Q · filed 2026-08-05 | $1.13B derived: sum of 3 quarters · filed 2026-08-05 | $1.48B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $359.40M 10-Q · filed 2026-05-07 | $780.60M derived: sum of 2 quarters · filed 2026-05-07 | $1.13B derived: sum of 3 quarters · filed 2026-05-07 | $1.47B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $421.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $771.90M derived: sum of 2 quarters · filed 2026-02-27 | $1.11B derived: sum of 3 quarters · filed 2026-02-27 | $1.40B 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $350.70M 10-Q · filed 2025-11-05 | $687.20M derived: sum of 2 quarters · filed 2025-11-05 | $975.20M 10-Q · filed 2025-11-05 | $1.30B derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $336.50M 10-Q · filed 2025-08-06 | $624.50M 10-Q · filed 2025-08-06 | $951.30M derived: sum of 3 quarters · filed 2026-02-27 | $1.21B derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $288.00M 10-Q · filed 2025-05-07 | $614.80M derived: sum of 2 quarters · filed 2026-02-27 | $873.10M derived: sum of 3 quarters · filed 2026-02-27 | $1.13B derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $326.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $585.10M derived: sum of 2 quarters · filed 2026-02-27 | $839.40M derived: sum of 3 quarters · filed 2026-02-27 | $1.08B 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $258.30M 10-Q · filed 2024-11-07 | $512.60M derived: sum of 2 quarters · filed 2024-11-07 | $749.60M 10-Q · filed 2024-11-07 | $984.50M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $254.30M 10-Q · filed 2024-08-09 | $491.30M 10-Q · filed 2024-08-09 | $726.20M derived: sum of 3 quarters · filed 2025-03-03 | $930.20M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $237.00M 10-Q · filed 2024-05-10 | $471.90M derived: sum of 2 quarters · filed 2025-03-03 | $675.90M derived: sum of 3 quarters · filed 2025-03-03 | $900.20M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $234.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $438.90M derived: sum of 2 quarters · filed 2025-03-03 | $663.20M derived: sum of 3 quarters · filed 2025-03-03 | $873.00M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $204.00M 10-Q · filed 2023-11-09 | $428.30M derived: sum of 2 quarters · filed 2023-11-09 | $638.10M 10-Q · filed 2023-11-09 | $854.30M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $224.30M 10-Q · filed 2023-08-09 | $434.10M 10-Q · filed 2023-08-09 | $650.30M derived: sum of 3 quarters · filed 2024-02-29 | $845.80M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $209.80M 10-Q · filed 2023-05-10 | $426.00M derived: sum of 2 quarters · filed 2024-02-29 | $621.50M derived: sum of 3 quarters · filed 2024-02-29 | $816.50M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $216.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $411.70M derived: sum of 2 quarters · filed 2024-02-29 | $606.70M derived: sum of 3 quarters · filed 2024-02-29 | $796.30M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $195.50M 10-Q · filed 2022-11-04 | $390.50M derived: sum of 2 quarters · filed 2022-11-04 | $580.10M 10-Q · filed 2022-11-04 | $780.30M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $195.00M 10-Q · filed 2022-08-05 | $384.60M 10-Q · filed 2022-08-05 | $584.80M derived: sum of 3 quarters · filed 2023-03-01 | $751.90M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $189.60M 10-Q · filed 2022-05-06 | $389.80M derived: sum of 2 quarters · filed 2023-03-01 | $556.90M derived: sum of 3 quarters · filed 2023-03-01 | $705.20M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $200.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $367.30M derived: sum of 2 quarters · filed 2023-03-01 | $515.60M derived: sum of 3 quarters · filed 2023-03-01 | $691.50M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $167.10M 10-Q · filed 2021-11-05 | $315.40M derived: sum of 2 quarters · filed 2021-11-05 | $491.30M 10-Q · filed 2021-11-05 | $669.90M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $148.30M 10-Q · filed 2021-08-05 | $324.20M 10-Q · filed 2021-08-05 | $502.80M derived: sum of 3 quarters · filed 2022-02-28 | $668.90M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $175.90M 10-Q · filed 2021-05-10 | $354.50M derived: sum of 2 quarters · filed 2022-02-28 | $520.60M derived: sum of 3 quarters · filed 2022-02-28 | $697.50M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $178.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $344.70M derived: sum of 2 quarters · filed 2022-02-28 | $521.60M derived: sum of 3 quarters · filed 2022-02-28 | $694.40M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $166.10M 10-Q · filed 2020-11-06 | $343.00M derived: sum of 2 quarters · filed 2020-11-06 | $515.80M 10-Q · filed 2020-11-06 | $682.20M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $176.90M 10-Q · filed 2020-08-07 | $349.70M 10-Q · filed 2020-08-07 | $516.10M derived: sum of 3 quarters · filed 2021-03-01 | $669.60M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $172.80M 10-Q · filed 2020-05-11 | $339.20M derived: sum of 2 quarters · filed 2021-03-01 | $492.70M derived: sum of 3 quarters · filed 2021-03-01 | $649.10M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $166.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $319.90M derived: sum of 2 quarters · filed 2021-03-01 | $476.30M derived: sum of 3 quarters · filed 2021-03-01 | $637.60M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $153.50M 10-Q · filed 2019-11-04 | $309.90M derived: sum of 2 quarters · filed 2019-11-04 | $471.20M 10-Q · filed 2019-11-04 | $632.10M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-06-30 | $156.40M 10-Q · filed 2019-08-09 | $317.70M 10-Q · filed 2019-08-09 | $478.60M derived: sum of 3 quarters · filed 2020-03-27 | $626.20M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-03-31 | $161.30M 10-Q · filed 2019-05-08 | $322.20M derived: sum of 2 quarters · filed 2020-03-27 | $469.80M derived: sum of 3 quarters · filed 2020-03-27 | $619.00M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2017-12-31 | $160.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $308.50M derived: sum of 2 quarters · filed 2020-03-27 | $457.70M derived: sum of 3 quarters · filed 2020-03-27 | $596.50M 10-K · filed 2020-03-27 | $598.30M 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $147.60M 10-Q · filed 2018-11-09 | $148.10M 10-Q · filed 2017-11-09 | $296.80M derived: sum of 2 quarters · filed 2018-11-09 | $435.60M 10-Q · filed 2018-11-09 | $436.80M 10-Q · filed 2017-11-09 | $577.30M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $149.20M 10-Q · filed 2018-08-09 | $149.90M 10-Q · filed 2017-08-09 | $288.00M 10-Q · filed 2018-08-09 | $288.70M 10-Q · filed 2017-08-09 | $429.70M derived: sum of 3 quarters · filed 2019-03-01 | $569.00M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $138.80M 10-Q · filed 2018-05-10 | $280.50M derived: sum of 2 quarters · filed 2019-03-01 | $419.80M derived: sum of 3 quarters · filed 2019-03-01 | $569.50M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $141.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $281.00M derived: sum of 2 quarters · filed 2019-03-01 | $430.70M derived: sum of 3 quarters · filed 2019-03-01 | $563.50M 10-K · filed 2019-03-01 | $565.30M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $139.30M 10-Q · filed 2017-11-09 | $289.00M derived: sum of 2 quarters · filed 2017-11-09 | $421.80M 10-Q · filed 2017-11-09 | $562.60M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $149.70M 10-Q · filed 2017-08-09 | $282.50M 10-Q · filed 2017-08-09 | $423.30M derived: sum of 3 quarters · filed 2018-03-16 | $562.60M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $132.80M 10-Q · filed 2017-05-10 | $273.60M derived: sum of 2 quarters · filed 2018-03-16 | $412.90M derived: sum of 3 quarters · filed 2018-03-16 | $550.70M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $140.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $280.10M derived: sum of 2 quarters · filed 2018-03-16 | $417.90M derived: sum of 3 quarters · filed 2018-03-16 | $562.90M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $139.30M 10-Q · filed 2016-11-09 | $277.10M derived: sum of 2 quarters · filed 2016-11-09 | $422.10M 10-Q · filed 2016-11-09 | $593.40M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $137.80M 10-Q · filed 2016-08-05 | $282.80M 10-Q · filed 2016-08-05 | $454.10M derived: sum of 3 quarters · filed 2017-03-01 | $616.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $145.00M 10-Q · filed 2016-05-06 | $316.30M derived: sum of 2 quarters · filed 2017-03-01 | $478.70M derived: sum of 3 quarters · filed 2017-03-01 | $643.80M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $171.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $333.70M derived: sum of 2 quarters · filed 2017-03-01 | $498.80M derived: sum of 3 quarters · filed 2017-03-01 | $657.90M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $162.40M 10-Q · filed 2015-11-06 | $327.50M derived: sum of 2 quarters · filed 2015-11-06 | $486.60M 10-Q · filed 2015-11-06 | $661.50M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $165.10M 10-Q · filed 2015-08-07 | $324.20M 10-Q · filed 2015-08-07 | $499.10M derived: sum of 3 quarters · filed 2016-02-29 | $660.80M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $159.10M 10-Q · filed 2015-05-08 | $334.00M derived: sum of 2 quarters · filed 2016-02-29 | $495.70M derived: sum of 3 quarters · filed 2016-02-29 | $653.80M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $174.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $336.60M derived: sum of 2 quarters · filed 2016-02-29 | $494.70M derived: sum of 3 quarters · filed 2016-02-29 | $657.00M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $161.70M 10-Q · filed 2014-11-07 | $319.80M derived: sum of 2 quarters · filed 2014-11-07 | $482.10M 10-Q · filed 2014-11-07 | $684.60M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $158.10M 10-Q · filed 2014-08-08 | $320.40M 10-Q · filed 2014-08-08 | $522.90M derived: sum of 3 quarters · filed 2015-02-27 | $672.70M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $162.30M 10-Q · filed 2014-05-09 | $364.80M derived: sum of 2 quarters · filed 2015-02-27 | $514.60M derived: sum of 3 quarters · filed 2015-02-27 | $680.70M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $202.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $352.30M derived: sum of 2 quarters · filed 2015-02-27 | $518.40M derived: sum of 3 quarters · filed 2015-02-27 | $673.40M 10-K · filed 2015-02-27 | $675.40M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $149.80M 10-Q · filed 2013-11-08 | $150.30M 10-Q · filed 2012-11-08 | $315.90M derived: sum of 2 quarters · filed 2013-11-08 | $470.90M 10-Q · filed 2013-11-08 | $472.40M 10-Q · filed 2012-11-08 | $635.90M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-06-30 | $166.10M 10-Q · filed 2013-08-08 | $322.10M 10-Q · filed 2013-08-08 | $486.10M derived: sum of 3 quarters · filed 2014-02-27 | $638.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $156.00M 10-Q · filed 2013-05-09 | $320.00M derived: sum of 2 quarters · filed 2014-02-27 | $471.90M derived: sum of 3 quarters · filed 2014-02-27 | $616.80M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $164.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $315.90M derived: sum of 2 quarters · filed 2014-02-27 | $460.80M derived: sum of 3 quarters · filed 2014-02-27 | $596.90M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $151.90M 10-Q · filed 2012-11-08 | $296.80M derived: sum of 2 quarters · filed 2012-11-08 | $432.90M 10-Q · filed 2012-11-08 | $577.40M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $144.90M 10-Q · filed 2012-08-09 | $281.00M 10-Q · filed 2012-08-09 | $425.50M derived: sum of 3 quarters · filed 2013-02-28 | $532.70M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $136.10M 10-Q · filed 2012-05-09 | $139.40M 10-Q · filed 2011-05-09 | $280.60M derived: sum of 2 quarters · filed 2013-02-28 | $387.80M derived: sum of 3 quarters · filed 2013-02-28 | $485.20M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | $144.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $251.70M derived: sum of 2 quarters · filed 2013-02-28 | $349.10M derived: sum of 3 quarters · filed 2013-02-28 | $448.30M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $107.20M 10-Q · filed 2011-11-09 | $204.60M derived: sum of 2 quarters · filed 2011-11-09 | $303.80M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $97.40M 10-Q · filed 2011-08-09 | $196.60M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | $99.40M 10-Q · filed 2011-05-09 | |||||||
| 2009-12-31 | $380.80M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |